The Long and Short of Disability

 

Depending on your condition and treatment regimen, you may need to take some time off from work. It is important to learn about short-term and long-term disability insurance plans that may be available to you. These plans can each cover a percentage of your salary if you can't work because of an illness or disability. But the long and short of it is, they each have their own rules.

Short-term disability insurance plans—There are two types of short-term plans: (1) a private policy that is offered through your employer or purchased on your own, and (2) state-sponsored policies. Five states—California, Hawaii, New Jersey, New York, and Rhode Island—and Puerto Rico currently have short-term disability insurance plans for employees, according to the U.S. Chamber of Commerce. Plans differ from state to state. They may begin as soon as 1 weeks' time and last up to 1 year. Contact your state’s insurance department for more information.

Long-term disability insurance plans—These plans can be private policies offered through your employer or purchased on your own. In addition, there are two long-term plans that are administered by the federal government. They usually start when short-term disability benefits end. Long-term disability benefits typically replace 60 percent to 70 percent of your income. You have to be qualified as disabled for 1 year or more to qualify. Contact your state’s insurance department or the Social Security Administration for more information.

This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Cancer News
Most women with cancer want a role in decisions

February 9, 2012 — NEW YORK (Reuters Health) - About two-thirds of women diagnosed with early stage breast cancer want to take part in making decisions about their treatment, according to a new survey of patients from five different countries.

Cancer trial participants may have misconceptions

February 9, 2012 — NEW YORK (Reuters Health) - People enrolled in early stage trials for possible cancer treatments may underestimate the risks involved and overestimate the potential benefits, suggests a new study.

U.S. FDA sets draft rules for biotech drug copies

February 9, 2012 —

Select news items provided by Reuters Health